| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4aaf127397fd5f114d8bfee1628e155e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate |
2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d8983f7a89b5204f68e8228ebc6f0b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a024e9b91815ba3a6b3e2f41125fd37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a281f8ca75af8208b1744854cc1a0b9 |
| publicationDate |
2012-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120082255-A |
| titleOfInvention |
Pharmaceutical composition comprising a peptide having leukocyte extravasation inhibitory activity and mast cell degranulation inhibitory activity |
| abstract |
The present invention provides a peptide fragment derived from allergin-1, a kind of transmembrane protein, that is, prevention of an inflammatory disease or allergy comprising a peptide consisting of an amino acid sequence of SEQ ID NO: 1 or a peptide consisting of an amino acid sequence of SEQ ID NO: 2 as an active ingredient. Or it provides a pharmaceutical composition for treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140101957-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11638744-B2 |
| priorityDate |
2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |